Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
33.83%
operating margin TTM
39.46%
revenue TTM
81.19 Million
revenue per share TTM
1.62$
valuation ratios | |
|---|---|
| pe ratio | 14.43 |
| peg ratio | -0.67 |
| price to book ratio | 1.88 |
| price to sales ratio | 4.90 |
| enterprise value multiple | 12.18 |
| price fair value | 1.88 |
profitability ratios | |
|---|---|
| gross profit margin | 63.77% |
| operating profit margin | 39.46% |
| pretax profit margin | 45.94% |
| net profit margin | 33.83% |
| return on assets | 12.01% |
| return on equity | 13.21% |
| return on capital employed | 15.0% |
liquidity ratios | |
|---|---|
| current ratio | 14.64 |
| quick ratio | 14.17 |
| cash ratio | 2.02 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 88.54 |
| operating cycle | 151.77 |
| days of payables outstanding | 112.35 |
| cash conversion cycle | 39.42 |
| receivables turnover | 5.77 |
| payables turnover | 3.25 |
| inventory turnover | 4.12 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 118.09 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.79 |
| cash per share | 4.64 |
| operating cash flow per share | 0.80 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 118.09 |
| short term coverage ratios | 131.37 |
| capital expenditure coverage ratio | 103.86 |
Frequently Asked Questions
When was the last time Clinuvel Pharmaceuticals Limited (PNK:CLVLY) reported earnings?
Clinuvel Pharmaceuticals Limited (CLVLY) published its most recent earnings results on 31-12-2025.
What is Clinuvel Pharmaceuticals Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Clinuvel Pharmaceuticals Limited (PNK:CLVLY)'s trailing twelve months ROE is 13.21%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Clinuvel Pharmaceuticals Limited (CLVLY) currently has a ROA of 12.01%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CLVLY's net profit margin stand at?
CLVLY reported a profit margin of 33.83% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CLVLY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 14.64 in the most recent quarter. The quick ratio stood at 14.17, with a Debt/Eq ratio of 0.00.